Type 2 diabetes mellitus (T2DM) arises from insulin resistance, characterized by reduced target organ sensitivity to insulin, coupled with insufficient pancreatic beta-cell insulin secretory capacity, collectively leading to hyperglycemia (Bielka et al., 2022). This evidence concerns the gene INS and Hyperglycemia.